Abstract: A feces collection sheet (S), which has a cylindrical shape and includes: an upper sheet (1) having a feces receiving portion (2) in a center of the upper sheet (1); and a lower sheet (9), which is provided so as to extend from both of a right-side edge portion and a left-side edge portion of the upper sheet (1) and is configured to define a gap with the upper sheet (1) to allow insertion of a toilet seat therethrough. The upper sheet (1) and the lower sheet (9) are made of a material having a water-soluble material property. The upper sheet (1) has a folded piece portion (10) adapted to be unfolded to enable the feces receiving portion (2) to form a three-dimensional shape that bulges toward the lower sheet (9).

Abstract: A feces collection sheet (S), which has a cylindrical shape and includes: an upper sheet (1) having a feces receiving portion (2) in a center of the upper sheet (1); and a lower sheet (9), which is provided so as to extend from both of a right-side edge portion and a left-side edge portion of the upper sheet (1) and is configured to define a gap with the upper sheet (1) to allow insertion of a toilet seat therethrough. The upper sheet (1) and the lower sheet (9) are made of a material having a water-soluble material property. The upper sheet (1) has a folded piece portion (10) adapted to be unfolded to enable the feces receiving portion (2) to form a three-dimensional shape that bulges toward the lower sheet (9).

Abstract: The invention includes: charging/discharging devices including storage batteries and having a grid-connected function to perform charging/discharging operations on an electric power system and an islanded-operation function to supply the electric power system with a constant-voltage constant-frequency electric power; a monitor detects an electric power state of the charging/discharging device and to transmit detection output to the charging/discharging device; and a switching unit connects and disconnects commercial power source to and from electric power system. When a commercial power source is normal, the switching unit connects the commercial power source to the electric power system and charging/discharging devices establish a grid connection.

Abstract: The present invention aims to provide a method for determining breast cancer susceptibility, in which a DNA copy number polymorphism associated with breast cancer susceptibility is identified and determination is made based on an increase or decrease in the DNA copy number polymorphism. The present invention attempts to achieve this by performing microarray assay using the peripheral blood of sporadic breast cancer patients, identifying a DNA copy number polymorphism associated with breast cancer susceptibility in a chromosomal region, detecting the number of copies of the above DNA copy number polymorphism by quantitative PCR, and then determining breast cancer susceptibility based on an increase or decrease in the DNA copy number polymorphism.

Abstract: The invention includes: charging/discharging devices including storage batteries and having a grid-connected function to perform charging/discharging operations on an electric power system and an islanded-operation function to supply the electric power system with a constant-voltage constant-frequency electric power; a monitor detects an electric power state of the charging/discharging device and to transmit detection output to the charging/discharging device; and a switching unit connects and disconnects commercial power source to and from electric power system. When a commercial power source is normal, the switching unit connects the commercial power source to the electric power system and charging/discharging devices establish a grid connection.

Abstract: The present invention aims to provide an assessment method of corpus uteri cancer susceptibility, in which a human chromosomal region consisting of a nucleotide sequence of approximately 100 bps that exhibits a DNA copy number polymorphism associated with corpus uteri cancer susceptibility is identified and assessment is made based on an increase or decrease in the DNA copy number polymorphism.

Abstract: The present invention aims to provide a method for determining breast cancer susceptibility, in which a DNA copy number polymorphism associated with breast cancer susceptibility is identified and determination is made based on an increase or decrease in the DNA copy number polymorphism. The present invention attempts to achieve this by performing microarray assay using the peripheral blood of sporadic breast cancer patients, identifying a DNA copy number polymorphism associated with breast cancer susceptibility in a chromosomal region, detecting the number of copies of the above DNA copy number polymorphism by quantitative PCR, and then determining breast cancer susceptibility based on an increase or decrease in the DNA copy number polymorphism.

Abstract: Disclosed is a method for determining the presence or absence of a colorectal tumor, specifically colorectal cancer or colorectal adenoma, with high sensitivity and high specificity by employing the methylation of DNA as a measure. Also disclosed is a kit for carrying out the method. Specifically, measurement is made on the degree of methylation of one or more CpG sequences contained in the region lying between positions -477 to -747, more preferably a CGCG sequence contained in the region lying between positions -688 to -691, in TWIST1 gene (Homo sapiens twist homolog 1; Drosophila gene) located on the genome sequence of a test cell.